Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; often called FRAP-associated protein (FRP1)) has emerged being a promising approach for cancer remedy that exploits artificial lethal interactions with proteins associated with DNA harm repair, overcomes resistance to other therapies and improves antitumour immunity. Several ... https://oligomycina22108.mybloglicious.com/47919678/article-under-review